{
    "code": "52027250",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027250",
    "time": "2022-04-22 04:31:42",
    "許可證字號": "衛部藥輸字第027250號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/02\/01",
    "發證\/登錄日期": "107\/02\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202725004",
    "中文品名": "優拓比膜衣錠1600微克",
    "英文品名": "UPTRAVI (CM) film-coated tablets 1600 mcg",
    "適應症": "用於肺動脈高血壓(WHO group I)且WHO 功能分級第II 至III級(WHO functional class II-III)之成人患者。本品應與內皮素受體拮抗劑(endothelin receptor antagonist, ERA)及\/或第五型磷酸二酯酶(phosphodiesterase type 5, PDE 5)抑制劑合併使用; 或單獨使用於病患無法適用內皮素受體拮抗劑且無法適用第五型磷酸二酯酶抑制劑時。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "112\/02\/01",
    "主成分略述": "Selexipag",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5E已執行國內臨床試驗 5F免除銜接性試驗",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FBE0049000  JANSSEN-CILAG INTERNATIONAL N.V.",
            "製造廠廠址": "TURNHOUTSEWEG 30, B-2340, BEERSE, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FCH8063000  ALLPACK GROUP AG",
            "製造廠廠址": "PFEFFINGERSTRASSE 45, 4153 REINACH BL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600400",
            "成分名稱": "Selexipag",
            "含量描述": "",
            "含量": "1.6000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Uptravi(CM)-劑量調整指南(病人)-TWc_EUPI Mar2021_v2101-111-03-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=009&Type=9"
        },
        {
            "title": "Uptravi(CM)-劑量調整指南(HCP)-TWc_EUPI Mar2021_v2101-111-03-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=008&Type=9"
        },
        {
            "title": "Uptravi(CM)-中文仿單-TWc_EUPI Mar2021_v2101-111-03-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=007&Type=9"
        },
        {
            "title": "藥輸027250 - 鋁箔_UPT(CM)-PF-1600-TWc_1517 pp02-109-11-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=005&Type=8"
        },
        {
            "title": "藥輸027250 - 外盒_UPT(CM)-PC-1600-TWc-1901 pp01-109-11-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=004&Type=8"
        },
        {
            "title": "優拓比膜衣錠1600mcg-藥輸027250-鋁箔-107-05-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=002&Type=8"
        },
        {
            "title": "優拓比膜衣錠1600mcg-藥輸027250-外盒-107-05-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027250&Seq=001&Type=8"
        }
    ]
}